Endonovo Therapeutics (ENDV) Short Interest Ratio & Short Volume $0.0001 0.00 (-50.00%) As of 08/4/2025 03:36 PM Eastern Add Compare Share Share Short Interest Stock AnalysisChartSEC FilingsShort InterestBuy This Stock Endonovo Therapeutics Short Interest DataEndonovo Therapeutics (ENDV) has a short interest of 599,100 shares. This marks a -1.63% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.4, indicating that it would take 0.4 days of the average trading volume of 7.78 million shares to cover all short positions.Current Short Interest599,100 sharesPrevious Short Interest609,000 sharesChange Vs. Previous Month-1.63%Dollar Volume Sold Short$59.91Short Interest Ratio0.4 Days to CoverLast Record DateJuly 15, 2025Outstanding Shares1,206,610,000 sharesPercentage of Shares Shorted0.05%Today's Trading Volume6,002 sharesAverage Trading Volume7,783,725 sharesToday's Volume Vs. Average0% Short Selling Endonovo Therapeutics? Sign up to receive the latest short interest report for Endonovo Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartENDV Short Interest Over TimeENDV Days to Cover Over TimeENDV Percentage of Float Shorted Over Time Endonovo Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 7/15/2025599,100 shares $59.91 -1.6%N/A0.4 $0.00 6/30/2025609,000 shares $121.80 -1.6%0.1%0.1 $0.00 6/15/2025619,000 shares $123.80 No Change0.1%0 $0.00 5/31/2025619,000 shares $61.90 No Change0.1%0.1 $0.00 5/15/2025619,000 shares $123.80 No Change0.1%0.2 $0.00 4/30/2025619,000 shares $123.80 No ChangeN/A0 $0.00 4/15/2025619,000 shares $123.80 No Change0.1%0 $0.00 3/31/2025619,000 shares $123.80 +54.8%0.1%0 $0.00 3/15/2025400,000 shares $80.00 +300.0%0.0%0 $0.00 2/28/2025100,000 shares $20.00 No Change0.0%0 $0.00 Get the Latest News and Ratings for ENDV and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Endonovo Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 1/15/2025100,000 shares $40.00 +2.6%N/A0 $0.00 12/31/202497,500 shares $39.00 -2.5%N/A0 $0.00 12/15/2024100,000 shares $70.00 No ChangeN/A0 $0.00 11/30/2024100,000 shares $70.00 +15.2%N/A0 $0.00 11/15/202486,800 shares $78.12 No ChangeN/A0 $0.00 10/31/202486,800 shares $95.48 No ChangeN/A0.6 $0.00 10/15/202486,800 shares $78.12 -0.1%N/A0.3 $0.00 9/30/202486,900 shares $86.90 +0.1%N/A1 $0.00 9/15/202486,800 shares $121.52 No ChangeN/A0.2 $0.00 8/31/202486,800 shares $121.52 No ChangeN/A0 $0.00 8/15/202486,800 shares $86.80 No ChangeN/A0.1 $0.00 7/15/202410,000 shares $10.00 No ChangeN/A0 $0.00 4/15/20248,300 shares $26.56 No ChangeN/A0 $0.00 3/15/202410,000 shares $35.00 No ChangeN/A0.1 $0.00 2/15/202427,000 shares $118.80 +130.8%N/A0 $0.00 1/15/202421,300 shares $208.74 +309.6%N/A0 $0.01 12/31/20235,200 shares $45.24 -73.2%N/A0 $0.01 12/15/202319,400 shares $176.54 +9,600.0%N/A0 $0.01 11/30/2023200 shares $2.30 No ChangeN/A0 $0.01 10/31/20233,700 shares $51.43 No ChangeN/A0 $0.01 9/15/20231,500 shares $16.67 No ChangeN/A0 $0.01 8/31/20231,500 shares $19.05 -60.5%N/A0 $0.01 8/15/20233,800 shares $41.80 -39.7%N/A0 $0.01 7/31/20236,300 shares $69.30 No ChangeN/A0.1 $0.01 6/30/2023300 shares $4.35 No ChangeN/A0 $0.01 4/30/202341,700 shares $417.00 -3.0%N/A0.1 $0.01 4/15/202343,000 shares $712.51 +15.0%N/A0.1 $0.02 3/31/202337,400 shares $617.10 No ChangeN/A0.1 $0.02 2/15/202322,300 shares $367.95 +2,377.8%N/A0 $0.02 1/31/2023900 shares $16.92 +50.0%N/A0 $0.02Elon’s BIGGEST warning yet? (Ad)Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… The "experts" said Elon was finished and Tesla was headed for bankruptcy. Now they're saying the same thing, but Jeff has uncovered Tesla's next breakthrough.Click here to see why Tesla's about to prove everyone wrong... again. 1/15/2023600 shares $9.30 No ChangeN/A0 $0.02 12/15/2022300 shares $3.93 -78.6%N/A0 $0.01 11/30/20221,400 shares $9.94 -6.7%N/A0 $0.01 11/15/20221,500 shares $13.20 No ChangeN/A0 $0.01 10/31/20221,500 shares $12.00 -76.9%N/A0 $0.01 10/15/20226,500 shares $52.00 -13.3%N/A0 $0.01 9/30/20227,500 shares $55.50 No ChangeN/A0 $0.01 8/31/202229,000 shares $216.05 +28,900.0%N/A0.1 $0.01 8/15/2022100 shares $0.83 No ChangeN/A0 $0.01 7/15/20229,000 shares $90.00 -4.3%N/A0.1 $0.01 6/30/20229,400 shares $84.60 No ChangeN/A0 $0.01 2/28/202210,900 shares $196.20 +118.0%N/A0 $0.02 2/15/20225,000 shares $85.00 No ChangeN/A0 $0.02 9/15/2021800 shares $19.20 No ChangeN/A0 $0.02 8/13/2021600 shares $16.32 -98.7%N/A0 $0.03 7/30/202147,000 shares $1.18 thousand +526.7%N/A0.1 $0.03 7/15/20217,500 shares $269.25 No ChangeN/A0 $0.04 6/15/20212,900 shares $87.29 +93.3%N/A0 $0.03 5/28/20211,500 shares $50.10 -79.7%N/A0 $0.03 5/14/20217,400 shares $295.26 No ChangeN/A0 $0.04 4/15/202136,200 shares $1.09 thousand No ChangeN/A0 $0.03 3/15/202115,300 shares $676.26 No ChangeN/A0 $0.04 2/26/202115,300 shares $612.00 -55.7%N/A0 $0.04 2/12/202134,500 shares $2.67 thousand No ChangeN/A0 $0.08 1/15/20219,400 shares $545.20 -45.7%N/A0 $0.06 12/31/20204,900 shares $129.04 -47.9%N/A0 $0.03 12/15/20209,400 shares $366.60 -45.7%N/A0 $0.04 11/30/202017,300 shares $934.20 +116.3%N/A0.1 $0.05 11/15/20208,000 shares $510.40 No ChangeN/A0.1 $0.06 10/15/20202,800 shares $234.92 -85.1%N/A0 $0.08 9/30/202018,800 shares $1.82 thousand +46.9%N/A0.1 $0.10 9/15/202012,800 shares $1.28 thousand No ChangeN/A0.3 $0.10 8/14/20205,900 shares $634.25 +51.3%N/A0 $0.11 ENDV Short Interest - Frequently Asked Questions What is Endonovo Therapeutics' current short interest? Short interest is the volume of Endonovo Therapeutics shares that have been sold short but have not yet been covered or closed out. As of July 15th, investors have sold 599,100 shares of ENDV short. Learn More on Endonovo Therapeutics' current short interest. Is Endonovo Therapeutics' short interest increasing or decreasing? Endonovo Therapeutics saw a decrease in short interest in the month of July. As of July 15th, there was short interest totaling 599,100 shares, a decrease of 1.6% from the previous total of 609,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Endonovo Therapeutics' short interest compare to its competitors? Here is how the short interest of companies in the industry of "medical equipment" compare to Endonovo Therapeutics: Arch Therapeutics, Inc. (0.15%), Non-Invasive Monitoring Systems Inc. (0.00%), T2 Biosystems, Inc. (0.09%), Helius Medical Technologies, Inc. (324.00%), SmileDirectClub, Inc. (0.42%), G Medical Innovations Holdings Ltd (0.00%), ViewRay, Inc. (0.17%), Acutus Medical, Inc. (0.00%), Sonendo, Inc. (0.12%), Nemaura Medical Inc. (0.00%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Coinbase Global, Inc. ($5.11 billion), Charter Communications, Inc. ($4.76 billion), Reddit Inc. ($2.84 billion), SoFi Technologies, Inc. ($2.79 billion), Seagate Technology Holdings PLC ($2.79 billion), Live Nation Entertainment, Inc. ($2.67 billion), Rocket Lab Corporation ($2.49 billion), AST SpaceMobile, Inc. ($2.12 billion), Moderna, Inc. ($2.09 billion), and Omnicom Group Inc. ($2.04 billion). View all of the most shorted stocks. What does it mean to sell short Endonovo Therapeutics stock? Short selling ENDV is an investing strategy that aims to generate trading profit from Endonovo Therapeutics as its price is falling. ENDV shares are trading down $0.00 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Endonovo Therapeutics? A short squeeze for Endonovo Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ENDV, which in turn drives the price of the stock up even further. How often is Endonovo Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ENDV, twice per month. The most recent reporting period available is July, 15 2025. More Short Interest Resources from MarketBeat Related Companies ARTH Short Interest NIMU Short Interest TTOO Short Interest HSDT Short Interest SDCCQ Short Interest GMVDF Short Interest VRAYQ Short Interest AFIB Short Interest RCAR Short Interest SONX Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:ENDV) was last updated on 8/5/2025 by MarketBeat.com Staff From Our PartnersMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredAmazon’s big Bitcoin embarrassmentBitcoin just passed Amazon in total market cap — but most investors are missing the bigger opportunity. Whi...Brownstone Research | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Endonovo Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Endonovo Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ENDV Stock Alerts